LasX and Surnetics sign Memorandum of Understanding for Developing IVD and other Microfluidic Products
News Sep 06, 2013
LasX’s patented LaserSharp® laser digital converting technology is ideal for the high volume manufacturing of next-generation microfluidic platforms because of its unmatched precision. Laser converting technology delivers a more accurate, efficient, and flexible solution for processing today’s complex microfluidic products, from prototype to full-scale production.
Surnetics develops technology solutions for enabling and improving liquid flow within channels in microfluidic products. Surnetics has developed a patent portfolio for gradient coatings; for example, a coating that changes in hydrophilicity (or other properties) over the length of the channel. This technology allows for fluid to flow through a channel without the need for pumps, valves, wicking strips, or any other external force. The technology can be used to control flow features on a product while greatly reducing the cost and size of the product.
Tom Daul, Program Development Manager for LasX stated, “Together, these enabling technologies allow customers to achieve more accurate, cost-effective microfluidic platforms than ever before.” Brian Babcock, President and founder of Surnetics added, "We are very pleased to establish this relationship with LasX. They have been an industry leader in the manufacture of precision, high volume microfluidic products for life sciences and bring a great deal of product design and manufacturing expertise that can be combined with Surnetics’ expertise in coatings and fluid flow optimization. This agreement presents a tremendous opportunity for both companies to develop new product platforms using our combined capabilities.”
Microanalysis of Biological Samples for Early Disease DetectionNews
A group of researchers from Osaka University has now developed a nonlinear optical crystal (NLOC) chip, which combines THz waves with a microfluidic device, utilizing the close proximity of the THz wave source and the solution of interest in a microchannel.READ MORE
Novel Green Chemistry Method Improves Pharmaceutical Manufacturing EfficiencyNews
About 70 percent of pharmaceuticals are manufactured using palladium-driven catalytic processes that are either fast or efficient - but not both. Researchers have now developed a green chemistry method that combines aspects of both processes to improve efficiency at a minimal cost of processing time.READ MORE
Radioprotective Drugs Assessed Using Human Gut Organ-on-a-ChipNews
Researchers have published a study using an organ-on-a-chip (Organ Chip) model of the human gut that reveals the intestinal blood vessel cells may play an important part in radiation-induced intestinal injury, and it confirms that a potential radioprotective drug, dimethyloxaloylglycine (DMOG), suppresses the intestine’s responses to radiation injury.READ MORE
Comments | 0 ADD COMMENT
Next Gen Regenerative Medicine & Tissue Engineering
May 29 - May 30, 2018